These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28258399)

  • 41. Cost-effectiveness of spinal manipulative therapy, supervised exercise, and home exercise for older adults with chronic neck pain.
    Leininger B; McDonough C; Evans R; Tosteson T; Tosteson AN; Bronfort G
    Spine J; 2016 Nov; 16(11):1292-1304. PubMed ID: 27345747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-value analysis of health interventions: introduction and update on methods and preference data.
    Nord E
    Pharmacoeconomics; 2015 Feb; 33(2):89-95. PubMed ID: 25488879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How you ask is what you get: Framing effects in willingness-to-pay for a QALY.
    Ahlert M; Breyer F; Schwettmann L
    Soc Sci Med; 2016 Feb; 150():40-8. PubMed ID: 26730880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-utility analysis of a pharmacotherapy follow-up for elderly nursing home residents in Spain.
    Jódar-Sánchez F; Martín JJ; López del Amo MP; García L; Araújo-Santos JM; Epstein D
    J Am Geriatr Soc; 2014 Jul; 62(7):1272-80. PubMed ID: 24891096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-Effectiveness of Bariatric Surgery Prior to Total Knee Arthroplasty in the Morbidly Obese: A Computer Model-Based Evaluation.
    McLawhorn AS; Southren D; Wang YC; Marx RG; Dodwell ER
    J Bone Joint Surg Am; 2016 Jan; 98(2):e6. PubMed ID: 26791039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of case-based training for primary care physicians in evidence-based medicine of patients with coronary heart disease.
    Groot-Jensen S; Kiessling A; Zethraeus N; Björnstedt-Bennermo M; Henriksson P
    Eur J Prev Cardiol; 2016 Mar; 23(4):420-7. PubMed ID: 25896863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-utility analysis of cataract surgery in the second eye.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
    Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
    BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
    Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
    Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life.
    Rowen D; Brazier J; Mukuria C; Keetharuth A; Risa Hole A; Tsuchiya A; Whyte S; Shackley P
    Med Decis Making; 2016 Feb; 36(2):210-22. PubMed ID: 26670663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Neuropharmacoeconomics].
    Chiu HC
    Acta Neurol Taiwan; 2004 Jun; 13(2):87-96. PubMed ID: 15478681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-Value Analysis and the SAVE: A Work in Progress, But an Option for Localised Decision Making?
    Karnon J; Partington A
    Pharmacoeconomics; 2015 Dec; 33(12):1281-8. PubMed ID: 26100285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-utility and cost-effectiveness of physical exercise during adjuvant chemotherapy.
    van Waart H; van Dongen JM; van Harten WH; Stuiver MM; Huijsmans R; Hellendoorn-van Vreeswijk JAJH; Sonke GS; Aaronson NK
    Eur J Health Econ; 2018 Jul; 19(6):893-904. PubMed ID: 29086085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of probabilistic decision models in technology assessment : the case of total hip replacement.
    Briggs A; Sculpher M; Dawson J; Fitzpatrick R; Murray D; Malchau H
    Appl Health Econ Health Policy; 2004; 3(2):79-89. PubMed ID: 15702945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The value of a QALY: individual willingness to pay for health gains under risk.
    Bobinac A; van Exel J; Rutten FF; Brouwer WB
    Pharmacoeconomics; 2014 Jan; 32(1):75-86. PubMed ID: 24293198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis.
    Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM
    Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgery for degenerative cervical myelopathy: a patient-centered quality of life and health economic evaluation.
    Witiw CD; Tetreault LA; Smieliauskas F; Kopjar B; Massicotte EM; Fehlings MG
    Spine J; 2017 Jan; 17(1):15-25. PubMed ID: 27793760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
    Roe RH; Lass JH; Brown GC; Brown MM
    Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alternatives to the quality-adjusted life year: How well do they address common criticisms?
    Rand LZ; Melendez-Torres GJ; Kesselheim AS
    Health Serv Res; 2023 Apr; 58(2):433-444. PubMed ID: 36537647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Economic examination of the 2006/7 update of the Israeli national list of health services].
    Shmueli A; Nissan-Englcin E
    Harefuah; 2008 Jun; 147(6):488-92, 576. PubMed ID: 18693622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.